Menu Search
Equities

Envista Holdings Corp

NVST:NYQ

Envista Holdings Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)20.39
  • Today's Change-1.01 / -4.72%
  • Shares traded1.65m
  • 1 Year change-5.99%
  • Beta1.2978
Data delayed at least 15 minutes, as of Nov 09 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Envista Holdings Corp had net income fall from a gain of 243.10m to a loss of 100.20m despite flat revenues. A contributing factor has been an increase in the percentage of sales devoted to the cost of goods sold from 42.07% to 43.48%.
Gross margin54.20%
Net profit margin-53.42%
Operating margin-51.42%
Return on assets-21.93%
Return on equity-36.31%
Return on investment-25.27%
More ▼

Cash flow in USDView more

In 2023, Envista Holdings Corp increased its cash reserves by 54.89%, or 333.10m. The company earned 275.70m from its operations for a Cash Flow Margin of 10.74%. In addition the company generated 118.90m cash from financing while 62.40m was spent on investing.
Cash flow per share-7.01
Price/Cash flow per share--
Book value per share17.86
Tangible book value per share0.2477
More ▼

Balance sheet in USDView more

Envista Holdings Corp has a Debt to Total Capital ratio of 31.63%, a lower figure than the previous year's 32.17%.
Current ratio2.08
Quick ratio1.77
Total debt/total equity0.4626
Total debt/total capital0.3163
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items dropped -144.80%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		-817.48
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.